CTNM
Contineum Therapeutics Inc. - Ordinary Shares - Class A

142
Mkt Cap
$323.05M
Volume
687,885.00
52W High
$16.25
52W Low
$3.35
PE Ratio
-4.85
CTNM Fundamentals
Price
$10.95
Prev Close
$12.22
Open
$10.97
50D MA
$11.38
Beta
0.46
Avg. Volume
92,386.78
EPS (Annual)
-$1.63
P/B
1.77
Rev/Employee
$0.00
Loading...
Loading...
Contineum Therapeutics, Inc. is a clinical stage biopharmaceutical company, which focuses on discovering and developing novel, oral small molecule therapies for neuroscience, inflammation, and immunology indications with high unmet need. The company was founded by Daniel S. Lorrain on May 9, 2017 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
41

Frequently Asked Questions

What is Market Cap of Contineum Therapeutics Inc. - Ordinary Shares - Class A?
What is the 52-week high for Contineum Therapeutics Inc. - Ordinary Shares - Class A?
What is the 52-week low for Contineum Therapeutics Inc. - Ordinary Shares - Class A?
What is Contineum Therapeutics Inc. - Ordinary Shares - Class A stock price today?
What was Contineum Therapeutics Inc. - Ordinary Shares - Class A stock price yesterday?
What is the PE ratio of Contineum Therapeutics Inc. - Ordinary Shares - Class A?
What is the Price-to-Book ratio of Contineum Therapeutics Inc. - Ordinary Shares - Class A?
What is the 50-day moving average of Contineum Therapeutics Inc. - Ordinary Shares - Class A?
How many employess does Contineum Therapeutics Inc. - Ordinary Shares - Class A has?

Latest CTNM News

View

Advertisement|Remove ads.

Advertisement|Remove ads.